You are here

Results for vaccines

Tuesday 13 April 2021

New York, USA
The AstraZeneca-Oxford vaccine has been deployed against COVID-19 in at least 115 countries, some of them for several months now. But it was not until a few cases of a rare blood-clotting disorder — some fatal — emerged within the past month or so that many European nations began to rethink its use across all age groups. Public health experts, however, have expressed concern that publicity surrounding the rare vaccine-related reactions will fuel hesitancy. They continue to emphasize that the AstraZeneca-Oxford vaccine’s benefits far outweigh the risks. In many nations, it is the only vaccine available.
Tuesday 16 March 2021

New York, USA
New York Times reporting: The coronavirus must have infected someone with a weak immune system, allowing it to adapt and evolve for months into far more contagious variants, experts hypothesize. If true, the idea has implications for vaccination programs, particularly in countries that have not yet begun to immunize their populations, especially those with diabetes and other health conditions. People with compromised immune systems — such as cancer patients — should be among the first to be vaccinated, said a virus expert. The faster that group is protected, the lower the risk that their bodies turn into incubators for the world’s next supercharged mutant.
Node is premium Premium content
Wednesday 24 February 2021

Kuala Lumpur, Malaysia
Vaccinating the world against COVID-19 is one of mankind’s most critical non-wartime efforts ever. Many countries have developed ambitious, politically sensitive, and carefully sequenced vaccination plans, but executing them successfully will be a challenge. To succeed, policymakers should build three realistic assumptions into their vaccination planning for 2021 and beyond. First, delays are inevitable. By Swee Kheng Khor
Thursday 17 December 2020

Wellington, New Zealand
New Zealand is preparing to support its Pacific partners to access safe and effective COVID-19 vaccines at the earliest opportunity, NZ Foreign Affairs Minister Hon Nanaia Mahuta and Associate Foreign Affairs Minister Aupito William Sio said today in a joint statement.
Wednesday 16 December 2020

New York, USA
New York Times reporting: While many poor nations may be able to vaccinate at most 20% of their populations in 2021, some of the world’s richest countries have reserved enough doses to immunize their own multiple times over. “The high-income countries have gotten to the front of the line and cleared the shelves,” said Andrea Taylor, a Duke researcher who is studying the coronavirus vaccines contracts. But the outlook for most of the developing world is dire. Because of manufacturing limits, it could take until 2024 for many low-income countries to obtain enough vaccines to fully immunize their populations.
Node is premium Premium content
Thursday 6 December 2018

Geneva, Switzerland
Each year, some 700,000 people die from drug-resistant infections worldwide. But superbugs also pose a threat to the effectiveness of modern medicine; if left unaddressed, antimicrobial resistance (AMR) could make more infections untreatable, cancer therapies ineffective, routine surgeries impossible, and even childbirth unsafe. By Seth Berkley and Jeremy Farrar